E

Esperion Therapeutics

D
ESPR
USD
-0.1
(-4.5351%)
Market Closed
429,804.00
Volume
0.31
EPS
-
Div Yield
-2.476471
P/E
413,052,982.98
Market Cap
Today
-4.5351%
1 Week
2.934%
1 Month
2.683%
6 Months
-11.368%
12 Months
106.373%
Year To Date
-29.599%
All Time
0%

Title:
Esperion Therapeutics

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Do you need help or have a question?